Kungani futhi kanjani ukusebenzisa izidakamizwa "Naiz" (wamafutha)

I nomuthi "Naiz" (wamafutha) sisetshenziswa

- ukuze akhulule ukuvuvukala uhlelo zemisipha,

- lapho rheumatism articular syndrome ahambisanayo,

- sokuqaqamba kwamalunga we etiologies ehlukahlukene,

- phakathi sifo acute,

- osteochondrosis nge radicular syndrome,

- e ankylosing spondylitis.

Futhi, lesi sidakamizwa sisiza nge sciatica, i-osteoarthritis, ukuvuvukala nemisipha futhi imisipha, bursitis zivuvukale izicubu zomzimba ezithambile ngemva ukulimala.

Phakathi kwemisipha ubuhlungu zasezindaweni ezihlukahlukene, ngokuvamile kakhulu kutuswa ukusebenzisa imithi "Nise" (wamafutha). Yokusetshenziswa kuhilela isicelo ngezihloko ezihlukene izidakamizwa. Ngakho-ke ebangela nokuncipha ubuhlungu umfutho noma ukunyamalala iyehlisa ekuseni ukuqina ngokuhlanganyela nokuvuvukala. Ngaleyo ndlela kwande amplitude kanye nenani iminyakazo etholakalayo.

"Naiz" kuyinto izidakamizwa eqeda ukuvuvukala okuyinto ayiqukethe steroid. Ngaphezu injongo yayo eyinhloko, ithuluzi Ubuye antipyretic, anti, Ukupholisa ngomoya kanye isinyathelo analgesic. Ngenxa yethonya phezu enzyme ehilelekile synthesis prostaglandins, okuyizinto, esikhundleni salokho, thobeka kumiswa edema, ukuvuvukala, futhi ngenxa yalokho, ubuhlungu, izidakamizwa "Naiz" (wamafutha) uyakwazi iwukudambisa lezi zenzakalo.

Ngaphezu kwalokho, izidakamizwa kuvimbela nesenzakalo enobuthi imikhiqizo umoya-mpilo ngokushesha ukuwohloka, isb anezakhi antioxidant. Lapho isicelo ihlelwe ngokulandelana kwezihloko, umphumela uba obonakalayo ngemva cishe inyanga ukusetshenziswa.

Yokusetshenziswa

Kunconywa ukuba ageze futhi asule isikhumba sakho ngaphambi kokuba ubhalise mafutha anamakha phezu kwalo. Kufanele zisetshenziswe endaweni esiphezulu ngesisa iyunifomu ungqimba elincanyana akuyona izikhathi ezingaphezu kuka ezine ngosuku.

Ubude obuphelele yokwelashwa kunqunywa labo nekhono e ukuncika ubukhulu bale indawo isifo, kanye impendulo eyodwa isiguli emuthini.

Lapho kuqhubeka isikhathi eside ukuphatha kuyadingeka ukuze afeze ukuqapha ehlelekile umsebenzi so-renal. izindawo Wamafutha kabi kwesikhumba akudingekile ukuvala sigqoka occlusive.

Wamafutha "Nise": ukufundiswa contraindications imiphumela engemihle

ukusabela ezingezinhle usebenzisa "Naiz" wamafutha zingase zihluke. Lapho isicelo ihlelwe ngokulandelana kwezihloko, kungenzeka flaking, ukulunywa, isifuba isikhumba ukushintsha kombala. Nokho, lona wamuva akuyona isizathu ukuqedwa zomuthi. Endabeni isicelo okugcoba kuyinto ematfuba okuvela ukusabela ezingezinhle ezifana nesifo sohudo, isilungulela, gastralgia, ukucanuzela kwenhliziyo noma ukuhlanza, ulceration we mucosa emathunjini, ubuhlungu bekhanda nesiyezi, hematuria, nokugcinwa uketshezi, ukuntuleka kwegazi emzimbeni, nokungezwani komzimba nezinto ezifana ukuqubuka kwesikhumba noma anaphylactic ukushaqeka.

Futhi, uma usebenzisa lokhu izidakamizwa kungase kwandise isikhathi ukopha, thrombocytopenia, leukopenia, agranulocytosis. Esimeni ukusabela ezingezinhle kufanele ngokushesha ukuyeka ukushayana ngamaphutha abazali "Nise" (wamafutha) futhi uthintane nge onguchwepheshe.

iziguli esezikhulile, lokhu izidakamizwa iqondiswa ngokuqapha ngenxa yezinga walonyaka isifo senhliziyo, umfutho wegazi ophakeme, izinkinga zesisu, umsebenzi kwezinso noma ukuthambekela opha, ikakhulukazi ngokumelene ukwelashwa nge anticoagulants namanxusa antiplatelet. Sikashukela futhi kufanele ngokuqinile dosed izidakamizwa, njengoba iqukethe sucrose.

Kasibili ukusetshenziswa contraindicated "Nise" (wamafutha) phakathi nokukhulelwa kanye lactation. Nokho, uma umuthi ozofakwa, kungcono uyeke ukuncelisa ibele. Futhi akufanele zisebenza dermatoses futhi izilonda zesikhumba. Kufanele kuqashelwe ukuthi "Naiz" (wamafutha) akusho egeleza nolwelwesi lwamafinyila futhi ikakhulukazi - esweni. Wena ubuye abakwazi ukusebenzisa leli thuluzi for ekwelapheni izingane ezingaphansi kweminyaka emibili.

Ungasebenzisi leli hypersensitivity zemithi nimesulide, nezinye izingxenye nemithi, kanye namanye amanxusa anti-inflammatory hhayi equkethe ama, futhi acetylsalicylic acid.